Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6991)
All Articles published online
|
Publishing Process of This Article
|
May 6, 2019 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Marzuillo P, Guarino S, Esposito T, Di Sessa A, Orsini SI, Capalbo D, Miraglia del Giudice E, La Manna A. Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values. World J Clin Cases 2019; 7(9): 1021-1027 [PMID: 31123674 DOI: 10.12998/wjcc.v7.i9.1021] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v7/i9/1021.htm |
| Number | Citing Articles |
| 1 |
Shuichiro Fujinaga, Yuji Tomii. Profound effect of post-rituximab mycophenolate mofetil administration for persistent hypogammaglobulinemia in young children with steroid-dependent nephrotic syndrome. Clinical and Experimental Nephrology 2020; 24(4): 386 doi: 10.1007/s10157-020-01858-z
|
| 2 |
Erik N. Newman, Ryan B. Israelsen, Kayla Williamson, Elena W.Y. Hsieh. Hypogammaglobulinemia after rituximab therapy in children. Annals of Allergy, Asthma & Immunology 2022; 128(2): 225 doi: 10.1016/j.anai.2021.10.028
|
| 3 |
Yuta Inoki, Koichi Kamei, Kentaro Nishi, Mai Sato, Masao Ogura, Akira Ishiguro. Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome. Pediatric Nephrology 2022; 37(5): 1057 doi: 10.1007/s00467-021-05304-4
|
| 4 |
Tejas S. Athni, Sara Barmettler. Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab. Annals of Allergy, Asthma & Immunology 2023; 130(6): 699 doi: 10.1016/j.anai.2023.01.018
|
| 5 |
Aleksandra Zurowska, Magdalena Drozynska-Duklas, Rezan Topaloglu, Antonia Bouts, Olivia Boyer, Mohan Shenoy, Marina Vivarelli, H. Alpay, R. Andersen, G. Ariceta, B. Atmış, U. S. Bayrakçı, B. Esrea, V. Baudouin, N. Bervina, E. Benetti, E. Berard, A. Bjerre, M. Christian, A. Couderc, J. Dehoorne, G. Deschenes, C. Dossier, R. Düşünsel, Z. Ekinci, F. Emma, L. Espinoza, A. Gianviti, M. Herrero Goñi, G. Guido, L. Ghio, J. Groothoff, D. Ö. Hacıhamdioğlu, M. Espino Hernández, A. Jankauskiene, M. Kagan, M. Kemper, M. Kovacevic, S. Kohl, R. T. Kramar, M. López-González, A. M. Aris, S. Maringhini, M. Marlais, M. Melgosa, A. Mitsioni, G. Montini, A. Moczulska, L. Murer, V. Obukhova, J. Oh, P. Ortega, Z. B. Özçakar, T. Ulinski, A. Pasini, T. Papalia, S. Paunova, A. Pena, C. Pecoraro, E. Petrosyan, L. Peruzzi, N. Printza, L. Prikhodina, C. Pietrement, S. Rittig, D. Rodrigo, N. Savenkova, M. Saraga, F. L. Sever, M. Schreuder, M. Szczepanska, V. Tasic, B. Tonshoff, K. Tullus, J. Vara, J. Vande Walle, E. Volokhina, J. Zieg, A. Waters, L. T. Weber, N. Webbe, M. Wasiak, K. Endén, A. Tsygin, R. Grenda, A. Raes, J. M. Van Hoeck Koen, B. Adams, M. Aksenova, B. Ranchin, N. Hooman, I. Ogarek, T. Seeman, M. Fila, L. Oni, S. Mir, R. Novo, S. Stabouli, J. Vara-Martín, J. A. E. van Wijk, R. Ehren, Z. Bekassy, M. Herthelius, F. Becherucci, H. Shasha-Lavsky, F. Santos, M. Feldkötter, M. Pańczyk-Tomaszewska, J. Harambat, D. Grima, I. Gökçe, A. Teixeira, C. Licht, I. M. Schmidt, P. Brandström, N. Dinçel. Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey. Pediatric Nephrology 2023; 38(9): 3035 doi: 10.1007/s00467-023-05913-1
|
| 6 |
Annaliesse Blincoe, Roxane Labrosse, Roshini S. Abraham. Acquired B-cell deficiency secondary to B-cell-depleting therapies. Journal of Immunological Methods 2022; 511: 113385 doi: 10.1016/j.jim.2022.113385
|
| 7 |
Iris M. Otani, Heather K. Lehman, Artemio M. Jongco, Lulu R. Tsao, Antoine E. Azar, Teresa K. Tarrant, Elissa Engel, Jolan E. Walter, Tho Q. Truong, David A. Khan, Mark Ballow, Charlotte Cunningham-Rundles, Huifang Lu, Mildred Kwan, Sara Barmettler. Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees. Journal of Allergy and Clinical Immunology 2022; 149(5): 1525 doi: 10.1016/j.jaci.2022.01.025
|
| 8 |
Claire Dossier, Stéphanie Bonneric, Véronique Baudouin, Thérésa Kwon, Benjamin Prim, Alexandra Cambier, Anne Couderc, Christelle Moreau, Georges Deschenes, Julien Hogan. Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children. Clinical Journal of the American Society of Nephrology 2023; 18(12): 1555 doi: 10.2215/CJN.0000000000000288
|
| 9 |
Yuji Tomii, Chisato Umeda, Tomohiko Nishino, Yoshitaka Watanabe, Koji Sakuraya, Shuichiro Fujinaga. Hypogammaglobulinemia and infection after administration of rituximab for steroid-dependent nephrotic syndrome. Japanese journal of pediatric nephrology 2020; 33(1): 17 doi: 10.3165/jjpn.oa.2019.0156
|
| 10 |
Malgorzata Mikulska, Diana Averbuch. Infectious Complications in Biologic and Targeted Therapies. 2022; : 113 doi: 10.1007/978-3-031-11363-5_7
|
| 11 |
Lisa M. Ott de Bruin, Ingrid Pico-Knijnenburg, Monique M. van Ostaijen-ten Dam, Thomas J. Weitering, Dagmar Berghuis, Robbert G. M. Bredius, Arjan C. Lankester, Mirjam van der Burg. Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect. International Journal of Molecular Sciences 2023; 24(21): 16012 doi: 10.3390/ijms242116012
|
| 12 |
Roxane Labrosse, Sara Barmettler, Beata Derfalvi, Annaliesse Blincoe, Guilhem Cros, Jonathan Lacombe-Barrios, Julie Barsalou, Nancy Yang, Nora Alrumayyan, Jan Sinclair, Mei-Sing Ong, Carlos A. Camargo, Jolan Walter, Elie Haddad. Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients. Journal of Allergy and Clinical Immunology 2021; 148(2): 523 doi: 10.1016/j.jaci.2021.03.041
|
| 13 |
Yuta Inoki, Kentaro Nishi, Mai Sato, Masao Ogura, Koichi Kamei. The association between hypogammaglobulinemia severity and infection risk in rituximab-treated patients with childhood-onset idiopathic nephrotic syndrome. Pediatric Nephrology 2023; 38(2): 451 doi: 10.1007/s00467-022-05652-9
|